Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-01-18 @ 6:11 PM
Study NCT ID:
NCT05262959
Status:
COMPLETED
Last Update Posted:
2024-08-13
First Post:
2022-02-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC
Sponsor:
Shanghai Zhongshan Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
B2021-631R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None